Charles Schwab Investment Management Inc. Boosts Holdings in Teladoc Health, Inc. $TDOC

Key Points

• Charles Schwab Investment Management Inc. increased its stake in Teladoc Health by 5.2%, owning 2,571,673 shares worth approximately $20.47 million as of its latest filing.
• Teladoc Health reported an EPS of ($0.19) for the last quarter, exceeding analysts' expectations, but experienced a 1.6% decline in revenue compared to the same quarter last year.
• Hedge funds and institutional investors hold 76.82% of Teladoc Health’s stock, indicating strong institutional support despite mixed market performance and fluctuating target prices from various analysts.

Charles Schwab Investment Management Inc. boosted its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 5.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,571,673 shares of the health services provider's stock after buying an additional 127,960 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.47% of Teladoc Health worth $20,471,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Teladoc Health by 7.0% in the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock valued at $157,229,000 after buying an additional 1,289,183 shares during the last quarter. Monaco Asset Management SAM grew its position in Teladoc Health by 22.0% in the 1st quarter. Monaco Asset Management SAM now owns 500,000 shares of the health services provider's stock valued at $3,980,000 after buying an additional 90,000 shares during the last quarter. XTX Topco Ltd purchased a new position in Teladoc Health in the 1st quarter valued at $557,000. Deuterium Capital Management LLC purchased a new position in Teladoc Health in the 1st quarter valued at $159,000. Finally, Federated Hermes Inc. grew its position in Teladoc Health by 18.1% in the 1st quarter. Federated Hermes Inc. now owns 398,791 shares of the health services provider's stock valued at $3,174,000 after buying an additional 61,194 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 3,958 shares of the business's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider owned 17,645 shares of the company's stock, valued at approximately $121,044.70. The trade was a 18.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 5,808 shares of the business's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the transaction, the insider directly owned 69,773 shares of the company's stock, valued at $478,642.78. The trade was a 7.68% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on TDOC. Evercore ISI lifted their price objective on shares of Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a research report on Wednesday, July 9th. The Goldman Sachs Group decreased their target price on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Mizuho started coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 target price on the stock. Finally, Bank of America decreased their target price on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 28th. Six research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $9.80.

Teladoc Health Price Performance

Shares of NYSE:TDOC traded down $0.06 during midday trading on Wednesday, hitting $7.75. 3,595,850 shares of the stock were exchanged, compared to its average volume of 6,822,543. The stock has a market cap of $1.37 billion, a P/E ratio of -6.51 and a beta of 1.76. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a 50 day moving average price of $7.77 and a 200-day moving average price of $8.14.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. The business had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business's revenue was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, research analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.